IRTC — iRhythm Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for iRhythm Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-43.8	-101	-116	-123	-113
Depreciation
Non-Cash Items	79.4	100	145	159	195
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-56.2	-46.2	-65.5	-102	-99.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-13.8	-37.8	-23	-50.1	3.39
Capital Expenditures	-13.6	-28.1	-29.8	-40.4	-48.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-119	133	-22.6	39.2	-74
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	-132	105	-52.4	-1.21	-123
Financing Cash Flow Items	-10	-25.9	-0.077	0	-91.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	214	-28.6	26.7	8.82	511
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	68.2	38.9	-48.7	-42.7	392